脊柱关节炎中脱髓鞘疾病的发病率与预测因素:一项纵向队列研究数据
该纵向队列研究纳入2260例脊柱关节炎(SpA)患者,其中中轴型SpA(axSpA)与银屑病关节炎(PsA)患者按是否发生脱髓鞘疾病(DD)分组分析。SpA中DD平均发病率为每10万人年31例,axSpA 20年DD累积发病率高于PsA(1.30% vs 0.13%,P=0.01)。曾吸烟、axSpA诊断及合并炎症性肠病(IBD)是DD的预测因素,而TNF-α抑制剂治疗史不是预测因素。
要点
- SpA患者DD总体发病率低,平均发病率为每10万人年31例。
- axSpA的20年DD累积发病率高于PsA(1.30% vs 0.13%,P=0.01)。
- 曾吸烟、axSpA诊断和合并IBD预测DD发生,TNF-α抑制剂治疗史不是预测因素。
核心结论
- 该SpA队列中DD总体发病率低,axSpA的DD发病率高于PsA。
- axSpA诊断、合并IBD和曾吸烟预测DD发生,TNF-α抑制剂使用史未发现为DD预测因素。
研究设计与样本
- 从纵向队列数据库中识别axSpA和PsA患者,按是否发生DD分组分析。
- 共纳入2260例有随访数据的患者,采用竞争风险分析计算DD发病率,采用Cox回归(Fine和Gray法)评估DD预测因素。
主要发现
- 2260例患者中识别出18例DD事件,SpA平均发病率为每10万人年31例。
- axSpA的20年DD累积发病率为1.30%,PsA为0.13%(P=0.01)。
- 最佳预测模型中DD发生的风险因素包括曾吸烟(vs 从不吸烟)(HR 2.918,95%CI 1.037-8.214,P=0.0426)、axSpA(vs PsA)(HR 8.790,95%CI 1.242-62.182,P=0.0294)和合并IBD(vs 无IBD)(HR 5.698,95%CI 2.083-15.589,P=0.0007)。
- TNF-α抑制剂治疗史不是DD的预测因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The objectives of this study were to investigate the incidence of demyelinating disease (DD) among SpA patients and to identify risk factors that predict DD in this patient population. METHODS: Axial SpA (axSpA) and PsA patients were identified from a longitudinal cohort database. Each group was analysed according to the presence or absence of DD. Incidence rates (IRs) of DD were obtained, with competing risk analysis. Cox regression analysis (with Fine and Gray's method) was used to evaluate predictors of DD development. RESULTS: Among 2260 patients with follow-up data, we identified 18 DD events, corresponding to an average IR of 31 per 100 000 persons per year for SpA. The IR of DD at 20 years was higher in axSpA than in PsA (1.30% vs 0.13%, P = 0.01). The risk factors retained in the best predictive model for DD development included ever- (vs never-) smoking [hazard ratio (HR) 2.918, 95% CI 1.037-8.214, P = 0.0426], axSpA (vs PsA) (HR 8.790, 95% CI 1.242-62.182, P = 0.0294) and presence (vs absence) of IBD (HR 5.698, 95% CI 2.083-15.589, P = 0.0007). History of TNF-α inhibitor therapy was not a predictor of DD. CONCLUSION: The overall incidence of DD in this SpA cohort was low. Incident DD was higher in axSpA than in PsA. A diagnosis of axSpA, the presence of IBD, and ever-smoking predicted the development of DD. History of TNF-α inhibitor use was not found to be a predictor of DD in this cohort.
引用
- Remalante-Rayco P, Espiritu AI, Daghistani Y, et al. Incidence and predictors of demyelinating disease in spondyloarthritis: data from a longitudinal cohort study. Rheumatology (Oxford). 2024. PMID: 37792508. doi:10.1093/rheumatology/kead527
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。